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Hydatid disease is the result of human infection with 
the larval stages of the dog tapeworm, Echinococcus spp. 
Worldwide, considerable morbidity and mortality are 
associated with cystic (due to E. granulosus) and alveolar 
(due to E. multilocularis) hydatidosis, and in South 
America there are foci of polycystic disease due to E. 
vogeli and E. oligoartkrus. 
ECHINOCOCCUS GRANULOSUS 
Epidemiology and life cycle 
Cystic hydatid disease, the result of infection with E. 
granutosus, occurs in rural areas worldwide. Prevalence 
data are hard to estimate due to frequent under- 
diagnosis and under-reporting, but areas such as the 
Turkhana district in Kenya have annual incidences 
of up to 220 cases per 100 000 population [l]. Within 
countries, distribution is patchy. In the UK, as an 
example, in the mid-l980s, over 71% of English and 
Welsh patients apparently contracted their infection in 
Wales or Herefordshire, and there are also foci in the 
Western Isles of Scotland [2]. 
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Figure 1 Life cycle of Erhinococcur granulorus. 
The adult tapeworms live in the gastrointestinal 
tracts of canine definitive hosts, mostly dogs, wolves 
and foxes, and eggs are shed in feces. These are partially 
resistant to desiccation and may remain viable for 
several weeks. Sheep, the major intermediate hosts, 
become infected by eating pasture contaminated by 
these eggs. Within the intestine the oncosphere hatches 
from the egg, penetrates the gut wall, enters the portal 
circulation, and encysts in host viscera. The germinal 
layer of the developing cyst buds inwards, producing 
small internal vesicles known as brood capsules. The 
dog, or other canine, becomes infected by eating the 
mature larval cysts contained within the intermediate 
host’s viscera. Pigs, cattle, goats, horses and camels may 
also act as intermediate hosts (Figure 1). 
Humans are infected by ingesting the tapeworm 
eggs. These may be found adherent to the fur around 
the dog’s anus and mouth, or may be acquired through 
food or water contaminated by canine feces. 
Clinical features 
Many cysts are asymptomatic and only found inciden- 
tally or by screening in endemic areas. When symptoms 
occur they are most often due to the space-occupying 
nature of the cyst or to complications such as rupture. 
Over 50% of cysts occur within the liver, and the 
lung is involved in approximately 20% of cases, but they 
may form in any organ, including the kidneys, muscle, 
spleen, bone, breast, heart and brain (Figures 2 and 3). 
For hepatic cysts the most frequent symptom is 
abdominal pain [3,4] and hepatomegaly is common [5]. 
The main complication is rupture of the cyst. If this 
occurs, allergic phenomena, even anaphylaxis, are 
common, and if rupture occurs into the biliary tree 
then obstructive jaundice and cholangitis frequently 
occur. Rupture elsewhere may result in seeding of 
daughter cysts around the peritoneum or to other 
organs, resulting in significantly increased morbidity 
and vastly complicating treatment. Fortunately, such 
complications occur in fewer than 10% of patients. 
The natural history of untreated, uncomplicated 
cysts is poorly known, though it may be that as many 
as one third will spontaneously disappear or fail to grow 
further [6]. 
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Figure 2 CT scan of hepatic cystic hydatid disease. 
Figure 3 CT scan of cystic hydatid disease of the brain. 
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Diagnosis 
The diagnosis of cystic hydatid disease is usually made 
by a combination of clinical features, radiologic investi- 
gations and serology. 
Radiology 
Ultrasound is the imaging procedure most frequently 
employed, and specific features seen are the separation 
of the membrane from the wall of the cyst and the 
presence of daughter and collapsed cysts [7,8]. 
Comparison of ultrasound with C T  scanning and 
MRI generally shows that the former is superior overall 
[ S ] ,  though CT may be better in the presence of gas, 
calcification and extrahepatic cysts [ 10,111 and MRI may 
be superior at determining any communication with the 
bihary tree or the presence of superinfection [12,13]. 
Serology 
Exposure to the tapeworm can be established with 
ELISA, Western blot and other analyses [14]. Various 
reagents have been used in these tests and some have 
shown poor specificity; however, newer assays are more 
standardized. The most sensitive appears to be ELISA 
[15]. Sensitive and specific antigen and PCR assays have 
also been established but have not yet entered routine 
clinical practice. 
Other laboratory investigations 
Unless rupture has previously occurred, when eosino- 
philia and a high IgE level would be expected, these are 
often not helpful. 
Treatment 
A variety of treatment protocols are used, incorpora- 
ting pharmacologic therapy, surgery and interventional 
radiology. 
Medical treatment 
Two drugs, albendazole and praziquantel, are used. 
Mebendazole, though it has some activity, appears to 
be less effective [16,17] and is now rarely indicated. 
There are no properly controlled clinical trials with 
these treatments, though large numbers of patients 
have been successfully treated. Albendazole, which is 
thought to have efficacy rates in the region of 60% 
[16,18], is commonly given in 28-day cycles (using 
400 mg b.i.d.) with a 2-week drug-free period between, 
until clinical improvement is seen. There is little 
published information on the eficacy and dosage 
regimens of‘ praziquantel in humans [19,20], though in 
vitro and animal data support its use. 
Surgery 
Surgery offers good hope of complete cure; however, 
care must be taken to avoid spillage of cyst contents 
with resultant dissemination of disease and allergic 
reactions. The former may be decreased by the 
installation of scolicidal agents such as chlorhexidine, 
hydrogen peroxide, ethanol and cetrimide during 
surgery. Also, the combination of surgical treatment 
and a pre- and postoperative course of albendazole has 
been used with good results [21]. 
Surgery also has a role in palliation and in the 
correction of complications, particularly those involving 
the biliary tree, and, recently, laparoscopic techniques 
have been shown to be of some use [22]. 
lnterventional radiology 
Drainage of hepatic hydatidosis under ultrasound or 
CT guidance is becoming increasingly established, 
often with the injection of scolicidal agents in an 
attempt to sterilize the cyst. It appears to be safe, well 
tolerated and, particularly when combined with 
albendazole, of comparable efficacy to surgery [23-251. 
Prevention 
Hydatid control schemes incorporate the screening and 
regular ‘de-worming’ of dogs, control of strays, the 
prevention of domestic and sheep dogs eating the 
carcasses of home-butchered sheep or slaughterhouse 
waste, and health education. Considerable successes 
have been achieved in Iceland, Tasmania, New Zealand 
and Cyprus [26] and more recently in many other parts 
of the world, including Wales [27]. 
ECHINOCOCCUS MULTlL OCULA RIS 
The cause of alveolar hydatid disease, E. multilocularis, 
has a less widespread distribution and is only present in 
the northern hemisphere. There are endemic foci in 
northern areas of North America, mainland Europe, 
much of the former USSR and through the Middle 
East, India and China to northern Japan. The life cycle 
is similar to that of E. granulosus but the definitive hosts 
are Arctic and red foxes, only occasionally domestic 
dogs and cats, and the intermediate hosts are rodents 
and other small mammals. The main cause of the 
differences in pathology is that the budding of the 
germinal layer of the developing parent cyst occurs 
externally, not internally as for E. granulosus, and this 
results in lesions which can be markedly locally invasive 
and can metastasize, with many sdarit ies to carcinoma. 
The liver is affected in over 90% of all cases, causing 
abdominal pain, hepatomegaly, jaundice and general 
constitutional symptoms [28,29]. Portal hypertension 
and the Budd-Chiari syndrome may occur, and 
secondary bacterial infection of the cysts produces high 
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morbidity and mortality. Lesions often metastasize to 
the lungs and nervous system, though any organ may 
be affected. 
Diagnosis is again mostly by a combination of 
clinical features, serology and radiology. Specific and 
sensitive ELISA assays have been designed [30]. Plain 
abdominal X-ray films may show evidence of calcifica- 
tion, particularly in long-established disease, but ultra- 
sound and CT scanning are most usefd [31]. As the 
individual cysts are small they are rarely visualized, and 
imaging more usually shows alternating high- and low- 
density areas. MRI  is less useful. 
Treatment is surgical. Attempts should be made 
at radical removal but, as with carcinoma, micro- 
protrusions and micro-metastases are common and 
result in relapses. In vitro experiments suggest that 
mebendazole, albendazole and praziquantel should 
have some activity, but the limited human in vivo data 
suggests that this would be inadequate as sole therapy. 
The combination of drug treatment and surgery may 
be promising. Interventional radiology has no role to 
Play. 
ECHINOCOCCUS VOGELI AND ECHINOCOCCUS 
OLIGOARTHRUS 
These tapeworms of bush dogs in South America rarely 
affect humans, in whom they cause polycystic hydatid 
disease. Budding of the parent cyst occurs internally 
and therefore it tends to lack the aggressive invasive 
nature of E.  multilocularis [32]. The liver is mostly 
affected (in 80%), and though surgery was previously 
considered as the standard treatment, in vivo data 
now suggest a role for an initial therapeutic trial of 
albendazole [33,34]. 
MULTIPLE-CHOICE QUESTIONS 
Hydatid disease 
Is due to human infection with the 
dog tapeworm larva True/False 
Has pigs as the most important 
intermediate hosts True/False 
May produce anaphylaxis if the cysts 
rupture True/False 
May affect any organ or tissue True/False 
Is too unreliably diagnosed sero- 
logically for this to be of use clinically True/False 
Cystic hydatid disease (due to E.  guunwlosus) 
Only occurs in the northern 
hemisphere True/False 
Is acquired by human contact with 
dead sheep True/False 
c) Predominantly affects the liver True/False 
d) Mebendazole is the drug of choice True/False 
e) Interventional radiology has a role in 
treatment True/False 
3. Alveolar hydatid disease (due to E. multilo- 
cwlaris) 
a) Can be treated with drugs alone True/False 
b) Is locally invasive with similarities to 
carcinoma True/False 
c) Radiology usually shows cysts within 
the affected organ True/False 
d) Has a worldwide distribution True/False 
e) May cause the Budd-Chiari syndrome True/False 
4. Polycystic hydatid disease 
a) May be treated by drugs alone True/False 
b) Only occurs in foci in South America True/False 
c) Is due to E. vogeli and E. oligoarthrur True/False 
d) Has rodents as it’s definitive hosts True/False 
e) Is the most aggressive type of hydatid 
disease True/False 
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ANSWERS 
4 1 :  a. True; b. False; c. True; d. True; e. False 
4 2 :  a. False; b. False; c. True; d. False; e. True 
43: a. False; b. True; c. False; d. False; e. True 
44: a. True; b. True; c.  True; d. False; e. False 
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